| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| INPAT | INPAT_ICD10(B59) | Pneumocystosis | 329 | |
| OUTPAT | OUTPAT_ICD10(B59) | Pneumocystosis | 162 | |
| OUTPAT | OUTPAT_ICD10(B580) | Toxoplasma oculopathy | 60 | |
| OUTPAT | OUTPAT_ICD10(B54) | Unspecified malaria | 34 | |
| OUTPAT | OUTPAT_ICD10(B509) | Plasmodium falciparum malaria, unspecified | 33 | |
| INPAT | INPAT_ICD10(B509) | Plasmodium falciparum malaria, unspecified | 27 | |
| OUTPAT | OUTPAT_ICD10(B589) | Toxoplasmosis, unspecified | 23 | |
| INPAT | INPAT_ICD8(13000) | Toxoplasmosis, Acquired | 20 | |
| INPAT | INPAT_ICD9(1302A) | Chorioretinitis due to toxoplasmosis | 14 | |
| INPAT | INPAT_ICD8(13099) | Toxoplasmosis, Unspecified | 13 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(B54) | Unspecified malaria. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 12 | |
| INPAT | INPAT_ICD10(B580) | Toxoplasma oculopathy | 10 | |
| INPAT | INPAT_ICD9(0840A) | Falciparum malaria [malignant tertian] | 10 | |
| INPAT | INPAT_ICD9(1309X) | Toxoplasmosis, unspecified | 10 | |
| DEATH | DEATH_ICD10(B59) | Pneumocystosis | 9 | |
| INPAT | INPAT_ICD8(08410) | Vivax malaria (benign tertian) | 9 | |
| INPAT | INPAT_ICD10(B500) | Plasmodium falciparum malaria with cerebral complications | 6 | |
| OUTPAT | OUTPAT_ICD10(B551) | Cutaneous leishmaniasis | 6 | |
| INPAT | INPAT_ICD10(B519) | Plasmodium vivax malaria without complication | 5 | |
| INPAT | INPAT_ICD10(B589) | Toxoplasmosis, unspecified | 5 | |
| INPAT | INPAT_ICD8(08400) | Falicparum malaria (malignant tertian) | 5 | |
| INPAT | INPAT_ICD8(08497) | Malaria, Suspecta | 5 | |
| INPAT | INPAT_ICD8(08499) | Malaria, Unspecified forms | 5 | |
| INPAT | INPAT_ICD8(13020) | Toxoplasmosis, Late effects of intra-utrine infection | 5 | |
| INPAT | INPAT_ICD9(1363A) | Pneumocystosis | 5 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(B59) | Pneumocystosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 5 |